Cargando…

Finding the Best Thresholds of FEV(1) and Dyspnea to Predict 5-Year Survival in COPD Patients: The COCOMICS Study

BACKGROUND: FEV(1) is universally used as a measure of severity in COPD. Current thresholds are based on expert opinion and not on evidence. OBJECTIVES: We aimed to identify the best FEV(1) (% predicted) and dyspnea (mMRC) thresholds to predict 5-yr survival in COPD patients. DESIGN AND METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Almagro, Pere, Martinez-Camblor, Pablo, Soriano, Joan B., Marin, Jose M., Alfageme, Inmaculada, Casanova, Ciro, Esteban, Cristobal, Soler-Cataluña, Juan J., de-Torres, Juan P., Celli, Bartolome R., Miravitlles, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937394/ https://www.ncbi.nlm.nih.gov/pubmed/24587085 http://dx.doi.org/10.1371/journal.pone.0089866

Ejemplares similares

Prognostic assessment in COPD without lung function: the B-AE-D indices
por: Boeck, Lucas, et al.
Publicado: (2016)

Gender and respiratory factors associated with dyspnea in chronic obstructive pulmonary disease
por: de Torres, Juan P, et al.
Publicado: (2007)

Unravelling young COPD and pre-COPD in the general population
por: Cosío, Borja G., et al.
Publicado: (2023)

Respiratory symptoms and their determinants in the general Spanish population: changes over 20 years
por: Miravitlles, Marc, et al.
Publicado: (2022)

Determinants of blood eosinophil levels in the general population and patients with COPD: a population-based, epidemiological study
por: Miravitlles, Marc, et al.
Publicado: (2022)

Prevalence of reduced lung diffusing capacity and CT scan findings in smokers without airflow limitation: a population-based study
por: Garcia-Rio, Francisco, et al.
Publicado: (2023)

Palliative care and prognosis in COPD: a systematic review with a validation cohort
por: Almagro, Pere, et al.
Publicado: (2017)

Reliability of FEV(1)/FEV(6) to Diagnose Airflow Obstruction Compared with FEV(1)/FVC: The PLATINO Longitudinal Study
por: Perez-Padilla, Rogelio, et al.
Publicado: (2013)

Utility of FEV(1)/FEV(6) index in patients with multimorbidity hospitalized for decompensation of chronic diseases
por: Komal, Shakeel, et al.
Publicado: (2019)

Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease
por: Guerra, Beniamino, et al.
Publicado: (2018)

A new approach to grading and treating COPD based on clinical phenotypes: summary of the Spanish COPD guidelines (GesEPOC)
por: Miravitlles, Marc, et al.
Publicado: (2013)

Adverse health consequences in COPD patients with rapid decline in FEV(1 )- evidence from the UPLIFT trial
por: Kesten, Steven, et al.
Publicado: (2011)

Clinical Control Criteria to Determine Disease Control in Patients with Severe COPD: The CLAVE Study
por: Soler-Cataluña, Juan José, et al.
Publicado: (2021)

Lack of Clinical Control in COPD Patients Depending on the Target and the Therapeutic Option
por: Soler-Cataluña, Juan José, et al.
Publicado: (2023)

Role of quantitative CT in predicting postoperative FEV(1 )and chronic dyspnea in patients undergoing lung resection
por: Papageorgiou, Chrysovalantis V, et al.
Publicado: (2010)

The concept of control of COPD in clinical practice
por: Soler-Cataluña, Juan José, et al.
Publicado: (2014)

Agreement between a simple dyspnea-guided treatment algorithm for stable COPD and the GOLD guidelines: a pilot study
por: Cabrera, Carlos, et al.
Publicado: (2016)

Letter to the editor regarding: “Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care”
por: Almagro, Pere, et al.
Publicado: (2017)

Beyond FEV(1) in COPD: a review of patient-reported outcomes and their measurement
por: Jones, Paul, et al.
Publicado: (2012)

Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2015 and GOLD 2019 staging: a pooled analysis of individual patient data
por: García Castillo, Elena, et al.
Publicado: (2020)

Fixed Cut-Off for FEV1/FEV6 and FEV6 in Detection of Obstructive and Restrictive Patterns
por: Aghili, Rokhsareh, et al.
Publicado: (2013)

Measuring slow vital capacity to detect airflow limitation in a woman with dyspnea and a preserved FEV(1)/FVC ratio
por: Berton, Danilo Cortozi, et al.
Publicado: (2019)

Risk Factors for Mortality in Hospitalized Coronavirus Disease 2019 Patients
por: Dietl, Beatriz, et al.
Publicado: (2020)

The contribution of FEV(1) and airflow limitation on the intensity of dyspnea and leg effort during exercise. Insights from a real‐world cohort
por: Satia, Imran, et al.
Publicado: (2020)

Validation of clinical control in COPD as a new tool for optimizing treatment
por: Soler-Cataluña, Juan José, et al.
Publicado: (2018)

FEV(1) Is a Better Predictor of Mortality than FVC: The PLATINO Cohort Study
por: Menezes, Ana Maria B., et al.
Publicado: (2014)

Bronchodilator Response of FEV6 and FEV3 as Surrogates of Forced Vital Capacity
por: Mehrparvar, Amir Houshang, et al.
Publicado: (2014)

Genome organization and molecular characterization of the three Formica exsecta viruses—FeV1, FeV2 and FeV4
por: Dhaygude, Kishor, et al.
Publicado: (2019)

Cut-off value of FEV(1)/FEV(6) as a surrogate for FEV(1)/FVC for detecting airway obstruction in a Korean population
por: Chung, Kyung Soo, et al.
Publicado: (2016)

COPD heterogeneity: Gender differences in the multidimensional BODE index
por: de Torres, Juan P, et al.
Publicado: (2007)

FEV(1) is a stronger mortality predictor than FVC in patients with moderate COPD and with an increased risk for cardiovascular disease
por: Bikov, Andras, et al.
Publicado: (2020)

Impact and prevention of severe exacerbations of COPD: a review of the evidence
por: Halpin, David MG, et al.
Publicado: (2017)

Gender associated differences in determinants of quality of life in patients with COPD: a case series study
por: de Torres, Juan P, et al.
Publicado: (2006)

Discriminant Validity of a Single Clinical Question for the Screening of Inactivity in Individuals Living with COPD
por: Ramon, Maria Antonia, et al.
Publicado: (2022)

Forced Expiratory Volume in 6 s (FEV(6)) and FEV(1)/FEV(6) Values as a Viable Alternative for Forced Vital Capacity (FVC) and FEV(1)/FVC Values During Pregnancy in South East Nigeria: A Preliminary Study
por: Nwagha, U, et al.
Publicado: (2014)

Dose omission to shorten methacholine challenge testing: clinical consequences of the use of a 10% fall in FEV(1) threshold
por: Lévesque, Valérie, et al.
Publicado: (2018)

New GOLD classification: longitudinal data on group assignment
por: Casanova, Ciro, et al.
Publicado: (2014)

Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease
por: Lopez-Campos, José Luis, et al.
Publicado: (2020)

Allergen bronchoprovocation: correlation between FEV(1) maximal percent fall and area under the FEV(1) curve and impact of allergen on recovery
por: Durr, Sarah-Marie, et al.
Publicado: (2023)

Comorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary disease
por: Miravitlles, Marc, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0jpsttci7r2grso68konevc6b9